Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies
<p>Purpose: As whole-exome and whole-genome sequencing (WES/WGS) move into routine clinical practice, it is timely to review data that might inform the debate around secondary findings (SF) and the development of policies that maximize participant benefit.</p> <p>Methods:...
Автори: | Ormondroyd, E, Mackley, M, Fletcher, B, Parker, M, Watkins, H |
---|---|
Формат: | Journal article |
Опубліковано: |
Nature Publishing Group
2016
|
Схожі ресурси
Схожі ресурси
-
Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study
за авторством: Mackley, M, та інші
Опубліковано: (2018) -
A clinical and ethical evaluation of secondary findings in the era of clinical whole-genome sequencing
за авторством: Mackley, M
Опубліковано: (2017) -
Whole Exome Sequencing in South Africa: Stakeholder Views on Return of Individual Research Results and Incidental Findings
за авторством: Nicole Van Der Merwe, та інші
Опубліковано: (2022-06-01) -
Secondary findings in 421 whole exome-sequenced Chinese children
за авторством: Wen Chen, та інші
Опубліковано: (2018-09-01) -
BALSA: integrated secondary analysis for whole-genome and whole-exome sequencing, accelerated by GPU
за авторством: Ruibang Luo, та інші
Опубліковано: (2014-06-01)